D. E. Shaw & Co., Inc. - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 51 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$4,126,597
+60.9%
408,574
+58.0%
0.01%
+66.7%
Q3 2022$2,565,000
+1.6%
258,574
+0.2%
0.00%0.0%
Q2 2022$2,525,000
+0.4%
258,1740.0%0.00%
+50.0%
Q1 2022$2,515,000
-34.1%
258,174
-34.5%
0.00%
-33.3%
Q4 2021$3,819,000
+72.4%
394,159
+72.1%
0.00%
+50.0%
Q3 2021$2,215,000
+587.9%
229,030
+587.1%
0.00%
Q2 2021$322,00033,3330.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Exos Asset Management LLC 45,300$441,0000.23%
MMCAP International Inc. SPC 250,000$2,435,0000.12%
Atalaya Capital Management LP 40,000$386,0000.10%
Radcliffe Capital Management, L.P. 200,000$1,942,0000.06%
Arena Capital Advisors, LLC- CA 75,000$731,0000.06%
FIR TREE CAPITAL MANAGEMENT LP 150,000$1,449,0000.05%
Athanor Capital, LP 147,800$1,428,0000.05%
Woodline Partners LP 275,000$2,654,0000.05%
Ghisallo Capital Management LLC 125,000$1,208,0000.05%
SUVRETTA CAPITAL MANAGEMENT, LLC 300,000$2,922,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders